Apellis Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 3/6
Apellis Pharmaceuticals has a total shareholder equity of $264.3M and total debt of $457.2M, which brings its debt-to-equity ratio to 173%. Its total assets and total liabilities are $904.5M and $640.2M respectively.
Key information
173.0%
Debt to equity ratio
US$457.21m
Debt
| Interest coverage ratio | n/a |
| Cash | US$368.04m |
| Equity | US$264.33m |
| Total liabilities | US$640.16m |
| Total assets | US$904.48m |
Recent financial health updates
Health Check: How Prudently Does Apellis Pharmaceuticals (NASDAQ:APLS) Use Debt?
Jul 12
Is Apellis Pharmaceuticals (NASDAQ:APLS) Using Debt In A Risky Way?
Apr 18Is Apellis Pharmaceuticals (NASDAQ:APLS) Using Debt Sensibly?
Dec 14Recent updates
Apellis: Rare Kidney Disease Data Leads To Possible First To Market
Aug 09Health Check: How Prudently Does Apellis Pharmaceuticals (NASDAQ:APLS) Use Debt?
Jul 12What Apellis Pharmaceuticals, Inc.'s (NASDAQ:APLS) P/S Is Not Telling You
May 30It's Probably Less Likely That Apellis Pharmaceuticals, Inc.'s (NASDAQ:APLS) CEO Will See A Huge Pay Rise This Year
May 30Apellis Pharmaceuticals Strives For Recovery Despite Syfovre Setbacks
May 14Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
May 09Apellis Pharmaceuticals: Eye Disease Drug Syfovre On Comeback Trail - But Risks Remain
Feb 16With A 55% Price Drop For Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) You'll Still Get What You Pay For
Jul 19Analysts Are Betting On Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) With A Big Upgrade This Week
May 13Is Apellis Pharmaceuticals (NASDAQ:APLS) Using Debt In A Risky Way?
Apr 18Is Apellis Pharmaceuticals (NASDAQ:APLS) Using Debt Sensibly?
Dec 14Some Analysts Just Cut Their Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Estimates
Nov 09Apellis Pharmaceuticals: Trying To Develop A Blockbuster Franchise
Sep 28Financial Position Analysis
Short Term Liabilities: APLS's short term assets ($860.0M) exceed its short term liabilities ($169.2M).
Long Term Liabilities: APLS's short term assets ($860.0M) exceed its long term liabilities ($471.0M).
Debt to Equity History and Analysis
Debt Level: APLS's net debt to equity ratio (33.7%) is considered satisfactory.
Reducing Debt: APLS's debt to equity ratio has increased from 4.2% to 173% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: APLS has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if APLS has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.